Syndax Pharmaceuticals (NASDAQ: SNDX) reported Q2 EPS of ($0.47), versus ($440.52) reported last year. Revenue for the quarter came in at $305 thousand, versus $17 thousand reported last year.

For earnings history and earnings-related data on Syndax Pharmaceuticals (SNDX) click here.